STA
NTUS

Summit Trail Advisors’s Natus Medical Inc NTUS Stock Holding History

Summit Trail Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11
Closed – – 1840
2017
Q4 		$0 Buy
+11
New +$439 ﹤0.01% 2132

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return
VCM
Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

Summit Trail Advisors's NTUS Position: Q1 2018 in Review

Summit Trail Advisors sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 11 shares.

Summit Trail Advisors first reported a position in NTUS in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

  • Summit Trail Advisors reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 11 Natus Medical Inc shares in Q1 2018.
  • Summit Trail Advisors first reported a position in Natus Medical Inc in Q4 2017 and held it in 1 quarter.
  • Summit Trail Advisors's Natus Medical Inc position peaked at $0 in Q4 2017.
  • 184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.